Rūta Kinderytė, Martynas Špečkauskas, Janina Kučinskienė
Abstract
Knowledge of proper administration of the anticoagulant and antiplatelet drugs therapy in oculoplastic surgeries is essential in order to avoid haemorrhagic complications during the surgeries and early postoperative period. Majority of the patients, to whom antiglaucoma, cataract or other eye surgeries are performed, are of elderly age and regularly use blood thinners prescribed by the specialists of various specialities. It is usual to stop using the antithrombotic treatment prior to the eye surgery in order to reduce the risk of bleeding, which could lead to irreversible vision loss in postoperative period. Termination of blood-thinning medications treatment could result in thromboembolic complications, especially to patients who underwent coronary stent procedure, coronary bypass surgery or heart valve prosthetics surgery. In case systemic complications occur, the outcome could be worse than local eye complications, including negative life prognosis. It is sought to avoid any complication during the medical procedures, but it is not ophthalmologist’s competence to prescribe or dispense blood thinners. In order to guarantee professional collaboration among specialists it is essential to understand the importance of bloodthinning medications treatment for patients who have underwent certain eye surgery.
Keyword(s): anticoagulants; antiplatelet drugs; oculoplastic surgery.
DOI: 10.5200/sm-hs.2017.008
Full Text: PDF